Oculis Holding AG
(OCS - NASDAQ)
10,56 USD
📋 Profilo Aziendale

Oculis Holding AG is a biopharmaceutical company in the clinical development stage, specializing in the creation of innovative eye drop medications for various ocular conditions, addressing both the anterior and posterior segments of the eye.

|